Related Experiment Video
Updated: Jun 7, 2025

06:32
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.6K
Granulomatous prostatitis following Bacillus Calmette-Guérin therapy
Siddhi Hegde1, Dhairya A Lakhani2, Ion Prisneac3
1Department of Radiology, Massachusetts General Hospital, Boston, United States.
Journal of Clinical Imaging Science
|November 12, 2024
Summary
Granulomatous prostatitis (GP), a rare chronic prostatitis, presents imaging features that overlap with prostate cancer. Definitive diagnosis requires biopsy, even with suspicious MRI findings.
Area of Science:
- Urology
- Radiology
- Pathology
Background:
- Granulomatous prostatitis (GP) is a rare condition, affecting 0.65-1.5% of men with chronic prostatitis.
- Radiological findings of GP often mimic those of prostate adenocarcinoma, posing a diagnostic challenge.
Observation:
- Magnetic resonance imaging (MRI) may reveal diffuse or focal nodular low T2 signal.
- Diffusion-weighted imaging (DWI) can show high signal intensity with corresponding low apparent diffusion coefficient (ADC) values.
- Post-contrast imaging might demonstrate lesion enhancement or rim enhancement, suggestive of caseous necrosis or abscess formation.
Findings:
- The case involved a 70-year-old male with granulomatous prostatitis.
- The patient had a history of intravesicle bacillus Calmette-Guérin (BCG) administration.
- Overlapping imaging features between GP and prostate adenocarcinoma necessitate further investigation.
Implications:
- Suspicion of GP based on MRI requires biopsy for accurate diagnosis.
- Understanding these imaging characteristics aids in differentiating GP from prostate cancer.
- Prior intravesicle BCG administration is a relevant clinical context for GP presentation.
Keywords:
Bacillus Calmette–GuérinGranulomatous prostatitisProstateProstate imaging–reporting and data systemMore Related Videos
Related Concept Videos
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis III
305
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
305

